US Stock MarketDetailed Quotes

ARAV Aravive

Watchlist
  • 0.040
  • 0.0000.00%
Trading Jan 26 16:00 ET
2.95MMarket Cap-0.05P/E (TTM)

About Aravive Company

Aravive Inc is a clinical-stage biopharmaceutical company. It focuses on developing treatments designed to halt the progression of life-threatening diseases, including cancer and fibrosis. The company pipeline product Batiraxcept (formerly AVB-500) which is an ultra-high affinity decoy protein that binds to GAS6 and thereby prevents AXL signaling to inhibit metastasis and tumor growth and restore sensitivity to anti-cancer agents. Batiraxcept is currently being evaluated in multiple clinical trials.

Company Profile

SymbolARAV
Company NameAravive
Issue Price21.00
CEODr. Gail McIntyre, PhD
MarketNASDAQ
Employees23
Fiscal Year Ends12-31
Websitehttps://www.aravive.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Robert B. Geller
  • Chief Medical Officer
  • --
  • Maria Carolina Petrini
  • Chief Commercial Officer
  • --
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Lennar Corp
LEN
-0.02%
D.R. Horton
DHI
-0.05%
Apple
AAPL
-0.11%
Ecopetrol
EC
-0.39%
Petroleo Brasileiro SA Petrobras
PBR
-0.42%

Unlock the Full List